Clincosm LogoSign in Get a demo

Chronic Myelogenous Leukemia

Showing NaN - NaN of 34
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia Trial in Houston (TGRX-678)

Not yet recruiting
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Oct 12, 2023

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
Jan 20, 2023

Chronic Myelogenous Leukemia, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Trial in Worldwide (ABL001, ABL001 +

Active, not recruiting
  • Chronic Myelogenous Leukemia
  • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
  • Boston, Massachusetts
  • +18 more
Jan 19, 2023

Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Houston (iCaspase9-transduced T cells,

Active, not recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • iCaspase9-transduced T cells
  • AP1903
  • Houston, Texas
  • +1 more
Jul 22, 2022

Chronic Myelogenous Leukemia Patients Treated With Imatinib

Recruiting
  • Chronic Myelogenous Leukemia
  • Chart Review
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 8, 2022

Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Fayetteville, Arkansas
  • +22 more
Jun 29, 2021

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • +3 more
  • Duarte, California
  • +100 more
Jun 8, 2021

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Tetanus)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Tetanus
  • Houston, Texas
  • +1 more
Apr 20, 2020

Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (INCB018424)

Completed
Has Results
  • Acute Myeloid Leukemia
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2020

Acute Lymphoblastic Leukemia, Non Hodgkins Lymphoma, Myelodysplastic Syndrome Trial in Houston (drug, biological, radiation,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +8 more
  • Houston, Texas
  • +1 more
Jan 15, 2020

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Jan 13, 2020

Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia Trial in United States (Tacrolimus (ARM with Methotrexate),

Completed
Has Results
  • Acute Leukemia
  • +8 more
  • Tacrolimus (ARM with Methotrexate)
  • +7 more
  • Duarte, California
  • +29 more
Jan 2, 2019

Chronic Myelogenous Leukemia Trial in Houston (Lonafarnib (SCH66336), Imatinib Mesylate (Gleevec))

Completed
  • Chronic Myelogenous Leukemia
  • Lonafarnib (SCH66336)
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    M.D. Anderson Cancer Center
Nov 6, 2018

Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)

Completed
  • Chronic Myelogenous Leukemia
  • Hematologic Malignancies
  • San Francisco, California
  • +4 more
May 15, 2018

Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia Trial in Houston (IL-2)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +9 more
  • IL-2
  • Houston, Texas
  • +1 more
Apr 3, 2018

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Myeloproliferative Disorders Trial in Canada, United States (Clofarabine,

Terminated
  • Myelodysplastic Syndrome
  • +9 more
  • Phoenix, Arizona
  • +6 more
Feb 13, 2018

Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, B-cell Chronic Lymphocytic Leukemia Trial in Scottsdale, Atlanta,

Completed
  • Acute Lymphoblastic Leukemia
  • +4 more
  • Scottsdale, Arizona
  • +2 more
Nov 16, 2017

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)

Terminated
Has Results
  • Acute Myelogenous Leukemia
  • +3 more
  • Baltimore, Maryland
  • +3 more
Aug 16, 2016

Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Houston

Terminated
Has Results
  • Myelodysplastic and Myeloproliferative Disorders
  • +7 more
  • Houston, Texas
  • +1 more
Mar 29, 2016

Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston, Richmond (drug, other, genetic)

Completed
  • Acute Lymphocytic Leukemia
  • +3 more
  • Houston, Texas
  • +1 more
Apr 13, 2016

Leukemia, Chronic Myelogenous Leukemia Trial in Houston (Fludarabine, Busulfan, NK cell infusion:)

Completed
Has Results
  • Leukemia
  • Chronic Myelogenous Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 4, 2016

Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia Trial in Houston (TH-302)

Completed
  • Acute Myelogenous Leukemia
  • +5 more
  • Houston, Texas
    University of Texas M.D. Anderson Cancer Center
May 5, 2015

Chronic Myelogenous Leukemia Trial in Houston (Imatinib Mesylate (IM), TALL-104 cells)

Terminated
Has Results
  • Chronic Myelogenous Leukemia
  • Imatinib Mesylate (IM)
  • TALL-104 cells
  • Houston, Texas
    UT MD Anderson Cancer Center
May 29, 2014